Non categorizzato AstraZeneca-Sanofi RSV shot for children approved by FDA Luglio 17, 2023 0 commenti The United States Food and Drug Administration (FDA) approved on Monday Beyfortus or nirsevimab, a medicine developed by AstraZeneca plc and Sanofi SA used to prevent respiratory syncytial virus (RSV)… About the author:
Get involved!
Comments